動脈硬化
Online ISSN : 2185-8284
Print ISSN : 0386-2682
ISSN-L : 0386-2682
培養ラット大動脈平滑筋細胞におけるリポ蛋白異化過程におよぼすカルシウム拮抗薬の影響
藤原 隆一玉井 利孝高橋 貞夫前田 肇高井 博正久津見 恭典中井 継彦宮保 進
著者情報
ジャーナル オープンアクセス

1988 年 16 巻 3 号 p. 381-384

詳細
抄録
Current evidences suggest that calcium may play a pathogenic role in atherosclerosis. In cholesterolfed rabbits, calcium channel blockers such as nifedipine, verapamil and diltiazem have been demonstrated to exert antiatherogenic effects without reducing the diet-induced hypercholesterolemia. In the present study, rat aortic smooth muscle cells (SMC) were used to study the effects of verapamil, diltiazem and nicorandil on cellular interactions with human low density lipoprotein (LDL). Specific bindings of 125I-LDL to SMC were not significantly changed by these drugs. Specific internalization were significantly increased by verapamil and diltiazem at concentration of 10-4M compared to control. Only verapamil of three agents decreased significantly specific degradation of 125I-LDL at concentration of 10-4M. Nicorandil, 10-8 to 10-4M, did not affect catabolism of 125I-LDL in SMC. These findings indicated that these drugs affect the intracellular catabolism of LDL differently in SMC.
著者関連情報
© 一般社団法人 日本動脈硬化学会

This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.
https://creativecommons.org/licenses/by-nc-sa/4.0/
前の記事 次の記事
feedback
Top